Replies to post #11311 on DNAprint Genomics (DNAG)

[jcryan19]

I've been thinking about something close to that.

First I would split DNAP into two companies, one would have DNAWitness and Ancestry (maybe they could put this in CMIH) and the other would have all the medical products they are working on. I would then merge the medical side with a small drug company.

XKEM is sitting out there with problems, but they have a cancer fighting drug paclitaxel and another in the pipeline for sickle cell leukemia. The following link shows some of its promise.

http://ragingbull.lycos.com/mboard/boards.cgi?board=XKEM&read=1360


On the down side of this is that XKEM has been a bigger disappointment then DNAP.

Jim

[gunnabeoneday]

Hasn't one of the issues that's restrained DNAP from a viable alliance been how Tony (and us!) values the worth of his company and IP?

And if so, wouldn't this same issue be present for a pooled interest merger?

I don't know a lot about such mergers, but I would guess that equity value needs to be quantified for each participant.

[DougS.]

That's an interesting thought. I don't know much about those kinds of mergers. How does it work? By the sound of it, it's not actually a merger in the typical sense but an agreement where two companies share certain assets?